Synergic effects of R715, an antogonist of the bradykinin receptor subtype 1 (BK B1-R) which impaired angiogenesis, and dacarbazine on murine melanoma growth (2005)
- Authors:
- Autor USP: CHAMMAS, ROGER - FM
- Unidade: FM
- Subjects: MELANOMA; BRADICININA; QUIMIOTERÁPICOS; FÁRMACOS; RECEPTORES; RESUMOS (EVENTOS)
- Language: Inglês
- Imprenta:
- Publisher place: Ribeirão Preto
- Date published: 2005
- Source:
- Título: Applied Cancer Research - Supplement
- ISSN: 1808-5539
- Volume/Número/Paginação/Ano: n. 2, p. 98-99, res. P-073, November, 2005
- Conference titles: São Paulo research conference Cancer Today From Molecular Biology to treatment
-
ABNT
PINHEIRO, M. C et al. Synergic effects of R715, an antogonist of the bradykinin receptor subtype 1 (BK B1-R) which impaired angiogenesis, and dacarbazine on murine melanoma growth. Applied Cancer Research - Supplement. Ribeirão Preto: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 07 maio 2026. , 2005 -
APA
Pinheiro, M. C., Andrade, L. N. S., Nonogaki, S., Nantel, F., Battistini, B., Sirrois, P., & Chammas, R. (2005). Synergic effects of R715, an antogonist of the bradykinin receptor subtype 1 (BK B1-R) which impaired angiogenesis, and dacarbazine on murine melanoma growth. Applied Cancer Research - Supplement. Ribeirão Preto: Faculdade de Medicina, Universidade de São Paulo. -
NLM
Pinheiro MC, Andrade LNS, Nonogaki S, Nantel F, Battistini B, Sirrois P, Chammas R. Synergic effects of R715, an antogonist of the bradykinin receptor subtype 1 (BK B1-R) which impaired angiogenesis, and dacarbazine on murine melanoma growth. Applied Cancer Research - Supplement. 2005 ;( 2): 98-99.[citado 2026 maio 07 ] -
Vancouver
Pinheiro MC, Andrade LNS, Nonogaki S, Nantel F, Battistini B, Sirrois P, Chammas R. Synergic effects of R715, an antogonist of the bradykinin receptor subtype 1 (BK B1-R) which impaired angiogenesis, and dacarbazine on murine melanoma growth. Applied Cancer Research - Supplement. 2005 ;( 2): 98-99.[citado 2026 maio 07 ] - Bradykinin-dependent pathways are activated within tumor microenvironments new targets for therapy
- Hedgehog signaling pathway mediates tongue tumorigenesis in wild-type mice but non Gal3: Deficient mice
- Use of RNA interference to investigate ADAM23 function and its role breast cancer progression
- F-18-Fluoride PET/CT and Tc-99m-MDP SPECT/CT can detect bone cancer at early stage in rodents
- Deregulated expression of Nucleophosmin 1 in gastric cancer and its clinicopathological implications
- Bases da biologia molecular
- ADAM23 silencing in breast cancer is associated with capase-1 and DAPK-1 downregulation and resistance to anoikis
- Endostatin gene therapy enhances the efficacy of IL-2 in suppressing metastatic renal cell carcinoma in mice
- Epigenetic mechanisms control galectin-3 gene expression along murine melanoma progression
- Lack of galectin-3 modifies differentially Notch ligands in bone marrow and spleen stromal cells interfering with B cell differentiation
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
